{
    "clinical_study": {
        "@rank": "16466", 
        "arm_group": {
            "arm_group_label": "Caffeine", 
            "arm_group_type": "Experimental", 
            "description": "Caffeine 420mg, one time"
        }, 
        "brief_summary": {
            "textblock": "The principal aim of this study is to evaluate the presence of changes in cervical\n      vestibular evoked myogenic potentials (VEMPc) after acute intake of caffeine in healthy\n      subjects.\n\n      Secondarily, it wants to standardize normal values \u200b\u200bexam VEMPc in otorhinolaryngology\n      service of the hospital."
        }, 
        "brief_title": "The Effects of Caffeine on Vestibular Evoked Myogenic Potentials in Healthy Subjects", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Healthy Subjects", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  healthy subjects\n\n        Exclusion Criteria:\n\n          -  hearing impairment\n\n          -  caffeine abuse 24 hours before the test\n\n          -  medication remains\n\n          -  hypertension, dyslipidemia, diabetes mellitus or sleep disorders."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01693809", 
            "org_study_id": "0127/11"
        }, 
        "intervention": {
            "arm_group_label": "Caffeine", 
            "intervention_name": "Caffeine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Caffeine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Caffeine", 
            "Vestibular Evoked Myogenic Potentials", 
            "dizziness", 
            "vertigo", 
            "tinnitus"
        ], 
        "lastchanged_date": "September 29, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "S\u00e3o Paulo", 
                    "country": "Brazil"
                }, 
                "name": "Hospital do Servidor Publico Estadual"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Effects of Caffeine on Vestibular Evoked Myogenic Potentials in Healthy", 
        "overall_official": [
            {
                "affiliation": "Hospital do Servidor Publico Estadual", 
                "last_name": "Fabio Akira Suzuki, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Hospital do Servidor Publico Estadual", 
                "last_name": "Ana Maria Almeida Sousa, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Alteration of p13 and n23 latency and p13-n23 amplitude before and after caffeine intake.", 
            "safety_issue": "No", 
            "time_frame": "60 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01693809"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital do Servidor Publico Estadual", 
            "investigator_full_name": "Ana Maria Almeida de Sousa", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Hospital do Servidor Publico Estadual", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital do Servidor Publico Estadual", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}